These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11721472)

  • 1. Comparison of some antineoplastic drugs on inhibiting thrombin catalizing fibrinogen clotting in vitro.
    Lu D; Cao J; Huang Y; Gong L; Chen X; Chen E; Xu B
    Chin Med J (Engl); 1999 Nov; 112(11):1052-3. PubMed ID: 11721472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of oxalysine on plasma fibrinogen content in tumor-bearing mice (author's transl)].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):124-8. PubMed ID: 6214145
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
    Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
    Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of inhibition of the action of thrombin by the fibrinopeptides formed during the clotting of fibrinogen.
    Silver A; Murray M
    Thromb Diath Haemorrh; 1966 Jul; 16(1):277-95. PubMed ID: 6011260
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of ascorbate and histidine in fibrinogen protection against changes following exposure to a sterilizing dose of gamma-irradiation.
    Zbikowska HM; Nowak P; Wachowicz B
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):669-76. PubMed ID: 17890955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin like activity of Asclepias curassavica L. latex: action of cysteine proteases.
    Shivaprasad HV; Rajesh R; Nanda BL; Dharmappa KK; Vishwanath BS
    J Ethnopharmacol; 2009 May; 123(1):106-9. PubMed ID: 19429347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
    Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM; Anthony CT; Thomson JL; Woltering EA
    Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activity of captopril.
    Brecher AS; Murrey SJ; Gray KD; Poulimenos JN
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):99-105. PubMed ID: 18209575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the clotting curves of complex dynamic rigidity for fibrinogen-thrombin solutions.
    Kaibara M; Fukada E
    Biorheology; 1980; 17(3):255-9. PubMed ID: 7213992
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of blood clotting derived from prothrombin.
    Marciniak E; Murano G; Seegers WH
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):161-6. PubMed ID: 6071101
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine.
    Martini WZ
    Metabolism; 2007 Feb; 56(2):214-21. PubMed ID: 17224335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full and partial deuterium solvent isotope effect studies of alpha-thrombin-catalyzed reactions of natural substrates.
    Zhang D; Kovach IM
    J Am Chem Soc; 2005 Mar; 127(11):3760-6. PubMed ID: 15771510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.